Vaccines: latest news

Vaccines resources

  • Vaccines

    HIV vaccine researchers are still looking for a vaccine that would offer a significant degree of protection against HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Vaccines

    The promise of an effective HIV vaccine has always been just over the horizon, but more than 20 years after the identification of HIV, vaccines...

    From: HIV transmission & testing

    Information level Level 4

Vaccines features

Vaccines news from aidsmap

More news

Vaccines news selected from other sources

  • Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

    Theoretically, effective global implementation of existing HIV treatment and prevention tools could end the HIV/AIDS pandemic. However, from a practical standpoint, ending the HIV/AIDS pandemic without a vaccine is unlikely, according to a new commentary from Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

    10 October 2017 | Eurekalert Medicine & Health
  • Why HPV Vaccination Rates Remain Low in Rural States

    The problem the vaccine has faced is its link to a taboo in American culture: sexual activity among teenagers. Health-care providers are the biggest hurdle to getting more children vaccinated.

    11 September 2017 | MIT Technology Review
  • The 2017 Pipeline Report

    Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

    19 July 2017 | Treatment Action Group
  • Immune system may keep body from neutralizing HIV-1 virus

    Researchers at the University of Colorado Anschutz Medical Campus have discovered that a process protecting the body from autoimmune disease appears to prevent it from creating antibodies that can neutralize the HIV-1 virus, a finding that could possibly help lead to a vaccine that stimulates production of these antibodies.

    11 July 2017 | Eurekalert Medicine & Health
  • First vaccine shows gonorrhoea protection

    A vaccine has for the first time been shown to protect against gonorrhoea, scientists in New Zealand say. The vaccine, originally developed to stop an outbreak of meningitis B, was given to about a million adolescents in New Zealand between 2004 and 2006. Researchers at the University of Auckland analysed data from sexual health clinics and found gonorrhoea cases had fallen 31% in those vaccinated. The meachanism of protection is unknown. This particular vaccine is no longer available but the UK has been using a similar vaccine, though whether it will protect is also unknown.

    11 July 2017 | BBC
  • Does it ever make sense to target HPV screening at HIV-infected individuals?

    A number of recent studies have considered the case for HPV-related cancer prevention interventions that are targeted at specific populations. A recent study suggests that, given their more rapid progression to precancerous conditions, HIV positive women in sub-Saharan Africa should be given the multivalent HPV vaccine, as it already is to HIV-positive MSM in some high-income settings.

    05 July 2017 | BMJ
  • HIV vaccine boost generates higher immune response 6 to 8 years later

    Boosting Thai participants from the RV144 HIV vaccine trial 6 to 8 years after their initial vaccination generated higher immune responses compared with those seen immediately after RV144; however, these humoral and CD4+ T cell responses were short-lived and did not grow after subsequent boosting, according to recent data published in The Journal of Infectious Diseases.

    03 July 2017 | Healio
  • Should everyone be getting the HIV prevention pill as part of this HIV vaccine study?

    More than 500 people have signed up since December to be part of the country’s largest HIV vaccine trial, but some experts are crying foul over what they say is unequal access to the HIV prevention pill among participants.

    30 June 2017 | Bhekisisa
  • Top HIV expert is not donating to crowdfunding HIV vaccine campaign, says it's "Fake News"

    Dr. Carl W. Dieffenbach, head of the AIDS division of the US National Institutes of Health, has denounced an HIV vaccine crowdfunding campaign involving prominent stars. The major fundraising #ENDHIV campaign which features SIA, the campaign’s ambassador. Other celebrities include Zoe Saldana and Julianne Moore. Dr Dieffenbach's assessment is not pointed at the celebrities nor the organisation behind the campaign. It’s about the research of scientist, Dr. Paul, whom Dieffenbach asserts “is wrong” in his direction towards discovering the vaccine or cure promoted by the video and the campaign’s website Yet, the #ENDHIV video calls Dr. Paul’s work “a promising new AIDS cure.”

    17 June 2017 | imstilljosh
  • Slow start to landmark South African HIV vaccine trial

    Stringent global standards to enlist participants are slowing the process of volunteering to participate in South Africa’s ground-breaking HIV vaccine trial, known as HVTN 702.

    02 June 2017 | Medical Brief
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.